Literature DB >> 27562581

Structural sex differences at disease onset in multiple sclerosis patients.

Juan Ignacio Rojas1, Francisco Sánchez2, Liliana Patrucco2, Jimena Miguez2, Jorge Funes3, Edgardo Cristiano2.   

Abstract

BACKGROUND: Male sex is associated with worsening disability and a more rapid progression of multiple sclerosis (MS). This study analysed structural sex differences in magnetic resonance images of the brain, comparing women whose disease started before and after the menopause with a control group of men.
METHODS: This was a case control study in which female patients whose MS started before (Group 1) and after (Group 2) the menopause were included. The control group was matched by age, disease duration, Expanded Disability Status Scale and disease-modifying treatment. Patients were analysed according to demographic and clinical variables, as well as in terms of radiological measurements at disease onset and during the first 12 months of follow-up. These measurements included normalised total brain volume (NTBV), normalised cortical volume (NCV), normalised white matter volume, left and right hippocampus, the thalamus, brain stem volume, lesion load and percentage brain volume change. A linear regression model was used to analyse the data.
RESULTS: A total of 97 patients were included: 53 in Group 1 (27 females) and 44 in Group 2 (22 females). In Group 1, we observed a reduction in brain volume in males compared with females at disease onset in NTBV (p = 0.01), NCV (p = 0.001) and brain stem volume (p = 0.01). We did not observe differences in Group 2 at disease onset in the brain volumes analysed.
CONCLUSION: We observed structural sex differences in brain volume at disease onset in the pre-menopausal group. However, no structural differences were observed at disease onset between the sexes after the menopause had started.
© The Author(s) 2016.

Entities:  

Keywords:  Multiple sclerosis; sex differences; structural

Mesh:

Year:  2016        PMID: 27562581      PMCID: PMC5033107          DOI: 10.1177/1971400916666560

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  20 in total

Review 1.  Sex hormones: a role in the control of multiple sclerosis?

Authors:  Valentina Tomassini; Carlo Pozzilli
Journal:  Expert Opin Pharmacother       Date:  2006-05       Impact factor: 3.889

Review 2.  Environmental risk factors in multiple sclerosis aetiology.

Authors:  Ruth Ann Marrie
Journal:  Lancet Neurol       Date:  2004-12       Impact factor: 44.182

Review 3.  Estrogen and testosterone therapies in multiple sclerosis.

Authors:  Stefan M Gold; Rhonda R Voskuhl
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

Review 4.  Sex-related factors in multiple sclerosis susceptibility and progression.

Authors:  Rhonda R Voskuhl; Stefan M Gold
Journal:  Nat Rev Neurol       Date:  2012-03-27       Impact factor: 42.937

5.  Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

Authors:  C Confavreux; M Hutchinson; M M Hours; P Cortinovis-Tourniaire; T Moreau
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

6.  Gender-related differences in MS: a study of conventional and nonconventional MRI measures.

Authors:  R Antulov; B Weinstock-Guttman; J L Cox; S Hussein; J Durfee; C Caiola; M G Dwyer; N Bergsland; N Abdelrahman; M Stosic; D Hojnacki; F E Munschauer; D Miletic; R Zivadinov
Journal:  Mult Scler       Date:  2008-11-21       Impact factor: 6.312

Review 7.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

8.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

9.  Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study.

Authors:  Alexander Klistorner; Chenyu Wang; Con Yiannikas; Stuart L Graham; John Parratt; Michael H Barnett
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  2 in total

1.  The impairment of the functional system and fatigue at the onset of the disease predict reaching disability milestones in relapsing-remitting multiple sclerosis differently in female and male patients.

Authors:  Alina Ivaniuk; Yuliia Solodovnikova; Tetiana Marusich; Anatoliy Son
Journal:  Acta Neurol Belg       Date:  2020-09-30       Impact factor: 2.396

2.  Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)2D, but No Difference in Ratio of 25(OH)D/24,25(OH)2D and FGF23 Concentrations.

Authors:  Mariska C Vlot; Laura Boekel; Jolijn Kragt; Joep Killestein; Barbara M van Amerongen; Robert de Jonge; Martin den Heijer; Annemieke C Heijboer
Journal:  Nutrients       Date:  2019-11-15       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.